123 related articles for article (PubMed ID: 18197949)
1. The effectiveness of mood stabilizers and antiepileptic medication for the management of behaviour problems in adults with intellectual disability: a systematic review.
Deb S; Chaplin R; Sohanpal S; Unwin G; Soni R; Lenotre L
J Intellect Disabil Res; 2008 Feb; 52(Pt 2):107-13. PubMed ID: 18197949
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials.
Smith LA; Cornelius V; Warnock A; Bell A; Young AH
Bipolar Disord; 2007 Jun; 9(4):394-412. PubMed ID: 17547586
[TBL] [Abstract][Full Text] [Related]
3. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
Munch G; Godart N
Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
[TBL] [Abstract][Full Text] [Related]
4. The effectiveness of antipsychotic medication in the management of behaviour problems in adults with intellectual disabilities.
Deb S; Sohanpal SK; Soni R; Lenôtre L; Unwin G
J Intellect Disabil Res; 2007 Oct; 51(Pt 10):766-77. PubMed ID: 17803495
[TBL] [Abstract][Full Text] [Related]
5. Psychotropic medication for behaviour problems in people with intellectual disability: a review of the current literature.
Deb S; Unwin GL
Curr Opin Psychiatry; 2007 Sep; 20(5):461-6. PubMed ID: 17762588
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
Deb S; Unwin G; Deb T
J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
[TBL] [Abstract][Full Text] [Related]
7. Pharmacotherapy for mental health problems in people with intellectual disability.
Ji NY; Findling RL
Curr Opin Psychiatry; 2016 Mar; 29(2):103-25. PubMed ID: 26779860
[TBL] [Abstract][Full Text] [Related]
8. The effectiveness of antidepressant medication in the management of behaviour problems in adults with intellectual disabilities: a systematic review.
Sohanpal SK; Deb S; Thomas C; Soni R; Lenôtre L; Unwin G
J Intellect Disabil Res; 2007 Oct; 51(Pt 10):750-65. PubMed ID: 17803494
[TBL] [Abstract][Full Text] [Related]
9. Antiepileptic drugs with mood stabilizing properties and their relation with psychotropic drug use in institutionalized epilepsy patients with intellectual disability.
Leunissen CL; de la Parra NM; Tan IY; Rentmeester TW; Vader CI; Veendrick-Meekes MJ; Aldenkamp AP
Res Dev Disabil; 2011; 32(6):2660-8. PubMed ID: 21752594
[TBL] [Abstract][Full Text] [Related]
10. Treatments for late-life bipolar disorder.
Aziz R; Lorberg B; Tampi RR
Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
[TBL] [Abstract][Full Text] [Related]
11. Psychotropic medication use for adults and older adults with intellectual disability; selective review, recommendations and future directions.
Deutsch SI; Burket JA
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jan; 104():110017. PubMed ID: 32544599
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of newer anticonvulsant medications in bipolar spectrum mood disorders.
Evins AE
J Clin Psychiatry; 2003; 64 Suppl 8():9-14. PubMed ID: 12892536
[TBL] [Abstract][Full Text] [Related]
13. Acute inpatient treatment, hospitalization course and direct costs in bipolar patients with intellectual disability.
Wu CS; Desarkar P; Palucka A; Lunsky Y; Liu SK
Res Dev Disabil; 2013 Nov; 34(11):4062-72. PubMed ID: 24051362
[TBL] [Abstract][Full Text] [Related]
14. The effect of adjunctive mood stabilizers on antipsychotic utilization pattern and health resource utilization for Medicaid enrollees with schizophrenia.
Chen H; Kennedy WK; Dorfman JH; Fincham JE; Reeves J; Martin BC
Curr Med Res Opin; 2007 Jun; 23(6):1351-65. PubMed ID: 17559734
[TBL] [Abstract][Full Text] [Related]
15. [Determinants of psychotropic medication in adults with mild or moderate intellectual disabilities].
Schützwohl M; Voss E; Stiawa M; Salize HJ; Puschner B; Koch A
Nervenarzt; 2017 Nov; 88(11):1273-1280. PubMed ID: 27638741
[TBL] [Abstract][Full Text] [Related]
16. Adverse events and the relation with quality of life in adults with intellectual disability and challenging behaviour using psychotropic drugs.
Scheifes A; Walraven S; Stolker JJ; Nijman HL; Egberts TC; Heerdink ER
Res Dev Disabil; 2016; 49-50():13-21. PubMed ID: 26647003
[TBL] [Abstract][Full Text] [Related]
17. Psychotropic prescribing for persons with intellectual disabilities and other psychiatric disorders.
Edelsohn GA; Schuster JM; Castelnovo K; Terhorst L; Parthasarathy M
Psychiatr Serv; 2014 Feb; 65(2):201-7. PubMed ID: 24233105
[TBL] [Abstract][Full Text] [Related]
18. Empirical evidence for the use of lithium and anticonvulsants in children with psychiatric disorders.
Lopez-Larson M; Frazier JA
Harv Rev Psychiatry; 2006; 14(6):285-304. PubMed ID: 17162653
[TBL] [Abstract][Full Text] [Related]
19. The use of topiramate in mood stabilization.
Maidment ID
Ann Pharmacother; 2002; 36(7-8):1277-81. PubMed ID: 12086564
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of psychotropic medication use and association with challenging behaviour in adults with an intellectual disability. A total population study.
Bowring DL; Totsika V; Hastings RP; Toogood S; McMahon M
J Intellect Disabil Res; 2017 Jun; 61(6):604-617. PubMed ID: 28090687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
